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A Life Science in Its African Para- State
P. Wenzel Geissler
The twenty- first century is an age of para phenomena, not simply in the 
sense of a “millennial” age of mirage, specter, and occult imaginaries (e.g., 
see Comaroff and Comaroff 2000), but also in its reliance on absent pres-
ences. The prefix, denoting “beside, near, behind, and from” as well as “op-
posed and contrary to,” captures a conflation between original and copy, ob-
ject and imprint or shadow— or between model, mold, and cast object— that 
challenges contemporary social scholarship. Para- helps us to avoid alterna-
tive descriptors such as post- or anti- as in postdemocratic, postdevelopment, 
antipolitical— which draw attention to important features but miss the 
peculiar sense of things changing without losing their form. Democracy be-
comes para- democracy when its institutions and routines persist but demo-
cratic control evaporates, which is different from twentieth- century anti- or 
non- democracies, for example, in their various military guises, but yet not 
postdemocratic; the economy becomes a para- economy if informal or ille-
gal transactions, and formal ones cease to be distinguishable, and when this 
conflation operates across economic scale, from African bicycle mechan-
ics to British MPs; even contemporary “revolutions” have a whiff of para- 
about them— neither fundamental political- economic ruptures nor obvious 
counterrevolutions. The remnants of older social and political forms appear 
sometimes as “mere” performance, empty shells, and  sometimes solid and 
durable; insidious changes rather than obvious ruptures can be observed 
anywhere: more of the same things, and yet something very different.
In this edited volume we are particularly interested in the para- state in 
Africa— the ways in which the state, albeit changed or in unexpected ways, 
continues to work as structure, people, imaginary, laws, standards, and so 
on. The term helps us to avoid older normative understandings of the state, 
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as well as the resulting misleading notions of “weak” or even “disappearing” 
African statehood. The state, the authors in this collection agree, remains 
indubitably present and potent— if not always in control or fulfilling legiti-
mate expectations of control. Specifically, we shall explore the para- state 
through one of its foundational fields of action and main manifestations in 
the lives of its citizens: medical science.
Biomedical Science in Africa
Medical and medical- related bioscientific knowledge has been generated 
from and applied to tropical Africa for over a century, transforming global 
medical knowledge and health in Africa. Medical science, government, and 
citizenship were intertwined in this process, evolving from early twentieth- 
century concerns with the health of imperial soldiers and settlers and the 
maintenance of the African workforce, through visions of health care as 
part of the Christian mission endeavor, to mid- twentieth- century projects 
of melioration and progress embodied by the British Colonial Welfare and 
Development Acts of 1940 and 1945 and subsequent postcolonial develop-
mentalism and internationalism (Packard 1989; Comaroff and Comaroff 
1991; Vaughan 1991; Ranger 1992; Iliffe 1998; Hunt 1999; Harrison 2004; 
Tilley 2011).
While medical science’s structures resembled those of other life sciences— 
linking metropolitan institutions and collections to imperial stations and ex-
perimental sites— and shared their legitimizing narratives about enhancing 
the (ex- )colonies’ value and uplifting their inhabitants’ lives by triggering 
development, what marks biomedical science is its particular moral valence. 
Preoccupied with saving lives and reducing suffering, medical research is a 
science of human life itself, which intertwines technical, political, and moral 
action, as early missionaries were the first to appreciate. Further removed 
from economic calculus than, say, agriculture, livestock, or plant sciences, 
medicine’s good is hard to contest. Medicine occupies the high ground, and 
other life sciences often bolster their moral justification with claims to medi-
cal, life- sustaining effects beyond economics (often through arguments of 
nutrition, from colonial cash cropping to current gMo debates).
The “developmental state” of the late colonial and early postcolonial era 
tightly intertwined health, medical science, government and population, 
and social good. In theory a textbook biopolitical regime (if in reality less 
extensive and coherent [Vaughan 1991]), it envisioned government- paid 
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and regulated doctors and scientists, networked from metropolitan centers 
and capital cities to the margins of emerging national territories, conduct-
ing research on citizens to produce knowledge, which government then 
used to improve the health of the citizenry. Implicit to this was a particular 
notion of scientific knowledge as tool to improve human lives, of the state 
as an advocate of its people, and of citizens as default subjects of research 
and government.
Some historians of Africa observed that this developmental nation- state 
was only a brief moment in the African longue durée; an imposition lack-
ing the European original’s underlying experience, and presumably with less 
lasting effects (e.g., Vaughan 1991; Cooper 2002). While nation- building 
processes in Africa and Europe were obviously different, such historical rela-
tivization of the African state should not distract one from its promissory 
character. For generations of Africans, the state has shaped what the world 
looks like, where one places oneself in it, and where one wants it to move. 
Its institutions and processes have proven surprisingly durable, but it is col-
lective hopes and individual aspirations attached to the state that had the 
most long- lasting imprint on African lives and institutions (which might 
be the case in original European nation- states as well). In particular state 
medicine and medical science continue to emanate not simply power and 
sometimes fear, as Masquelier (2001) had it, but civic purpose and hope for 
(better) life (Prince 2013).
In recent decades this quintessentially modern tie between government 
and medicine has been affected by changes: epidemics of hiV, cancer, and 
noncommunicable diseases emerged; care facilities decayed, services were 
privatized, and market- inspired funding mechanisms and private insurances 
expanded; nongovernmental, transnational interventions became vital 
sources of disease- specific health care; and scientific research was, together 
with other life science work, reconstituted alongside decaying public insti-
tutions (see, e.g., Langwick 2011; Livingston 2012; Marsland and Prince 
2012; Prince 2013; Prince and Marsland 2013). Doctors move between gov-
ernment hospitals and private practices to gain livable incomes; patients 
with little hope of obtaining medicines from their government seek treat-
ment from ngos and research organizations; and medical scientists court 
global drug trials and seek international scholarships. As a consequence of 
this situation, visions of scientific government and government science have 
turned into nostalgic memories of past hopes in many postcolonial coun-
tries (e.g., Mbembe and Roitman 1995; De Boeck 1998; Werbner 1998a; 
4 P. Wenzel geiSSler
Ferguson 1999; Masquelier 2001; Geissler 2011; Tousignant 2013; Droney 
2014), and long- standing African misgivings about bioscientific technolo-
gies and associated economic interests have expanded from popular rumors 
to public arguments about the political economy of science (e.g., Feldman- 
Savelsberg, Ndonko, and Schmidt- Ehry 2000; White 2004; Fairhead, Leach, 
and Small 2005; Yahya 2007; Nordling 2012; see also Kelly and Fassin in this 
volume).
Despite these societal changes, the state has not disappeared. As the cases 
in this collection show, it remains tangible in the many people enrolled in 
its workforce, its buildings and circulations, and its habitual procedures and 
paper trails; it also remains present in people’s claims for care, in state pro-
viders’ determination to define policies and standards, and even in foreign 
donors’ insistence on working through state “partners.” And the state also 
persists in people’s memories of (better) functioning government services, 
which far from being “mere” nostalgia direct their longings for a better 
future. All this is not quite the same as the developmental state of old, but 
it is not yet something altogether different either— hence the para- tag as 
analytical parenthesis.
The loosening of the biopolitical compound between state, medicine, 
and science has also opened creative spaces. New formations of govern-
ment (for example, ngos, transnational sovereigns, global philanthropy, 
humanitarian interventionism, public- private partnerships, pharmaceutical 
multinationals, nationalist anti- science) and new modes of collectivization 
(sometimes labeled “biological,” “therapeutic,” “pharmaceutical,” or even 
“clinical trial citizenship” [Rose 1996; Ecks 2005; Nguyen 2005; Rose and 
Novas 2005]) have filled some of the spaces vacated by the nation- state with-
out providing a similarly totalizing collective whole. The aim of this edited 
volume is to explore the place of medical and related life science work in 
Africa within these changed frames, trying to avoid tropes of totalizing rup-
ture, and keeping the state in view, attending to its partial, residual, or lin-
gering, lateral, mimetic, or mediated, that is, para, effect in contemporary 
biopolitics. Medical experimentation and intervention have been critical in 
the making of twentieth- century, modern Africa; they remain central for 
our understanding of twenty- first- century Africa and its place in a world 
in which life as such has become a focus of government and knowledge 
 production.
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A Sense of Change
The millennial present feels different from the time of our childhoods during 
the last third of the twentieth century. This sense of discontinuity has been 
given different labels, depending on disciplinary origins, political orienta-
tion, and geographical location, focusing on different facets of a diffuse ex-
perience, or trying to capture convergences between disparate phenomena. 
Some broad terms have equally rapidly expanded their currency and lost 
purchase: globalization—for some producing homogeneity, for others di-
versification—provided an encompassing but somewhat vacuous analyti-
cal concept during 1980s and 1990s; neoliberalization was then helpful to 
foreground concrete political- economic processes—global and national 
wealth redistribution and evolving class conflicts—but tends toward eco-
nomic determinism, capital- conspiracy narratives, or overstretching causali-
ties, which obscures attendant political opportunities (see Ferguson 2010).
Different post- concepts such as post– Cold War, postsocialist, post- nation- 
state, post- democracy, or, from an African vantage point, post- postcolonial 
(Ombongi 2011) or second postcolonial (Comaroff and Comaroff 2000) focus 
on historical comparison, but by emphasizing rupture they lose specificity; 
they also raise the question of whether we really are post- in the sense of 
beyond, and what we are in rather than after. Other descriptions focus in-
stead on exemplary contemporary phenomena, such as humanitarianism 
and emergency (Fassin and Pandolfi 2010; Bornstein and Redfield 2011), 
nongovernmental politics (Feher 2007), biosecurity and epidemic prepared-
ness (Dry and Leach 2010), or bioeconomies (e.g., Rajan 2006; Cooper 
2007). This array of interrelated “key traits” of the contemporary configura-
tion then raises questions about the proportional weight of particular phe-
nomena, causal connections, and points of convergence.
Irrespective of the labels, for those who gained consciousness in the 1960s 
and 1970s, it suffices to switch on the kitchen radio to realize that ours, in-
deed, is a different world: delimited military- cum- humanitarian interven-
tions in global zones of abandonment and global scares about emergent 
infections and travelling, drug- resistant pathogens transform the face of 
public (now “global”) health; persistent low- level conflicts at ever- shifting 
margins, suicide bombings, drones, and extrajudicial rendition and execu-
tions reference a new face of politics; and impoverished and diseased masses, 
dependent upon transnational food and treatment programs points toward 
an emerging global economy of survival.
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In Africa this experience of rupture is accentuated by political and eco-
nomic upheavals and violence (see, e.g., De Boeck 1994, 1998; Ferguson 
1999). “Things fall apart” again, including the modernist edifice that Chi-
nua Achebe once had accused of disrupting an older social fabric. Nostalgic 
(or ironic) comparison between the present and one’s grandparents’ 1960s 
and 1970s is common in everyday conversations, political discourse, popu-
lar literature and music, and reflections about professional practice (see, e.g., 
Simpson 1998; Werbner 1998b; McGregor 2005; Nyairo 2005; Prince 2006), 
and not least among academics and scientists whose conditions of life and 
work have radically changed (see Arnaut and Blommaert 2009). Such tem-
poralities of contrast do not merely account for historical processes and ex-
periences but also give—interwoven with the materiality of present life and 
traces of pasts—texture to the present and orientation to actions and aspi-
rations (De Boeck 1998; Tousignant 2013).
This particular sense of time and of one’s place in time— the temporality 
of things- having- changed— marks contemporary social experience. Look-
ing back, the past before the change, whatever content and value one gives 
it, lies behind the rupture: the time of the long 1980s, between the postcolo-
nial then and an as yet unclear now. The para- state idiom aims to grasp this 
layering of temporal experience. In its temporal sense, para- also refers to 
the blurred vision produced by the filter of change; neither post one thing 
and not yet quite something else, para- captures a sense of historical uncer-
tainty, a temporality of doubt framed by the figure of historical contrast.
New Biopolitical Forms in Africa
One characteristic of the present is its focus on life. Many new social forms 
have physical well- being and optimization, scientific knowledge of life, the 
utilization of bodily materials, and mere human survival at their core. Con-
cerns with epidemics and pharmaceutical treatments; humanitarian emer-
gencies and interventions; and the prominent role of the life sciences in eco-
nomic value creation, in imaginaries of progress (and threat), and in debates 
about ethical values share an interest in life as such.
The government of life has been a feature of modern biopolitics through-
out the past centuries; what, according to Rose (2001, 5), is different in the 
present is that “the ideal of an omnipotent social state that would shape, 
coordinate, and manage the affairs of all sectors of society has fallen into 
disrepute. The idea of ‘society’ as a single, if heterogeneous, domain with 
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the national culture, a national population, a national destiny, coextensive 
with a national territory and the powers of a national political government 
has entered a crisis. In this new configuration the political meaning and 
salience of health and disease have changed.” As a result of this, bodies are 
no longer approached collectively, as in old- style public health, but as con-
tainers of “somatic individuality” (Rose 2001), bearers of traits and risks, 
and targets of individual management and maximization. Taking these in-
sights to Africa implies a shift: while among Western middle classes the new 
vital politics may be primarily about optimization, for many others, includ-
ing many Africans, life is increasingly about survival. Somatic individuality 
is here less about striving for physical perfection than about an individual-
ized struggle to keep the body going (see Marsland and Prince 2012).
This difference notwithstanding, Africa is particularly suitable for ex-
ploring the new vital politics. Contemporary political- cum- economic- cum- 
epidemiological changes of science and care, academia and government are 
more visible here than in European post- welfare societies, where lasting 
infrastructures, bureaucratic institutions, and administrative habits main-
tain a façade of stability and where decaying structures are overwritten by 
new ones. The proliferation of “nongovernmental politics” (see Feher 2007) 
is more obvious where kleptocratic governments have turned their backs 
on their nations. Privatization and reduced government budgets hit hard 
among people without personal equity; class contradictions become more 
radical here, separating those participating in global opportunities from the 
majority without access to education and employment and those who rely 
upon decaying public provisions from those who benefit from new private 
insurances and care providers. People’s survival depends here on innovative 
biopolitical forms—refugee camps or food drops, vaccination campaigns, 
treatment programs, or clinical trials.
Africa has for long been described as a “laboratory” (Tilley 2011), a 
site of knowledge production and “experimental governmentality” (Bon-
neuil 2000), where medical (and other life science) practices were tried out 
together with novel social orders. In fact, the trope of experimentation 
predates historical analysis and derives from the colonial lexicon itself (see 
Lachenal 2010). Recent decades witness an intensification and enlargement 
of experimentation, from small- scale experiments, which served as pilots for 
larger programs, to large- scale experimental interventions, producing and 
validating evidence as they go (see Nguyen 2009; Rottenburg 2009).1 In the 
near- absence of government health care, experimental formations have be-
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come vital for people’s survival and well- being; this includes experimenta-
tion sensu stricto, clinical trials, which provide health care and treatment. 
Medical experimentation has thus a particular place in contemporary Africa, 
referencing a wider spectrum of novel biopolitical forms between nation- 
state and medical science, which can be discerned more clearly and earlier in 
Africa than elsewhere.
The Nation- State Past
The origin and counterpoint for the designation of the present as para- state 
is the nation- state, in which territory and population, home and people fall 
in one and in which the influence of government extends from centers of 
power and knowledge toward the margins. Life as an object of knowledge 
and of regulation had a particular place in the modern nation- state, familiar 
from Foucault’s studies of “biopower.” Irrespective of its actual historical 
realization, this mid- twentieth- century vision of the government of life—
represented, for example, by the British social theorist Richard Titmuss 
(1907– 1973), whose work shaped the National Health Services in Britain 
and postcolonial Africa (Oakley 2004)— has been steadily eroded by the re-
placement of society (as in people, territory, and state) with market as orga-
nizational metaphor and the spread of the liberal dichotomy of the state 
versus the people (rather than the idea of the former as democratic embodi-
ment of the latter).
Over the course of a few decades, the generation of scientific knowledge, 
previously a privilege of state institutes and universities, has been changed 
by new modalities of funding, management, and audit and new notions of 
intellectual ownership and value; simultaneously, the utilization of scientific 
knowledge has been progressively privatized and moved out of the taken 
for granted core domains of national government—health care and educa-
tion. These changes affect the lives of citizens and their understanding of the 
nation as the principal space of rights, claims, and obligations: gradually the 
modern republic disappears from view. As noted, African institutions and 
idioms of nationhood of recent origin, dependent upon external funding 
and riddled by historical contradictions (see, e.g., Bayart, Ellis, and Hibou 
1999), suffered particularly from these political- economic assaults.
This said, African nation- states are not simply “weakened” (see Roitman 
2004) or reduced to an image or a specter (e.g., Masquelier 2001). The state 
remains in existence, embodied by millions of civil servants, the institu-
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tions they work in, and the regulations and standards they uphold; it is re-
vealed in the control and force it exercises over its boundaries and its people, 
and it serves as projection of expectations and claims and memories of past 
hopes. In many if not most African countries the state “works” less well for 
the majority of its people than it should (and maybe did, at some point), if 
working implies availing the possibilities of education or health care to the 
population at large, but the state’s place in biopolitical order has changed, 
not diminished.
A Para- State
To capture this transformation, our title uses the shorthand para- state. This 
term has historically shifting meanings; according to the Oxford English Dic-
tionary, a para- state is “an organization which takes on some of the roles of 
civil government or political authority; an agency through which the state 
operates indirectly; [also] an industry which is partially state- run,” while a 
para- statal is “an organization or industry, now esp. in some African coun-
tries, having political authority and serving the state indirectly” (oed, on-
line). In Africa the term historically often refers to state- owned industries 
and state interventions into the market, such as commodity boards. This use 
of para- state denotes an ambiguous conflation between state and non- state 
spaces—the state meddling in non- state spaces to bolster its power—which 
is antithetical to 1980s liberal economic policies (e.g., Colclough and Manor 
1993; Tangri 2000).
Our own use of the term shares connotations of ambiguity and trans-
gression, but it references the opposite operation: modeled upon a more 
recent version of para- statal reorganization, it describes a chunk of the origi-
nal nation- state that is parceled out and run differently, shaped by market 
operations. This para- state “takes on some of the roles” of the nation- state 
without being part of or coextensive with it, evolving next to, around, or in 
the interstices of the state, thriving in its cordoned- off segments, upon the 
traces and detritus of the state, and interpreting memories and visions of 
nation and state toward different ends.
The para- prefix references— as in other para- phenomena, such as para- 
science or para- politics— a creative relationship between new (bio)political 
forms and the state. The para- state emerges at times within the ruins or car-
cass of the older nation (for example, new regulatory, ethics, or patenting 
agencies implanted by global policies into older government structures); 
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it evokes images and memories of past forms or projects older visions and 
hopes onto the emergent structures of the future (as in resurrections of 
nationalist rhetoric in neoliberal economics); at times it revitalizes, zombie- 
like, partially and temporarily, older state structures or limbs of those struc-
tures (for example, hiV clinics within neglected hospitals, research outfits in 
decaying universities); at other times it utilizes, sometimes drains, what is 
left of state institutions (for example, recruiting drug trial participants from 
public clinics or hiring qualified professionals from government hospitals 
into disease control programs).
At the same time, the para- statal formation creates new organisms, un-
expected life forms and associations, homunculi and phoenixes, such as 
the South African hiV Treatment Action Campaign, which challenges the 
nation- state on its own grounds, calling for scientific progress and demand-
ing the equal distribution of its fruits (see Robbins 2008) or the momentary 
rebirth of an assertive nation- state, as in Fassin’s example in this volume of 
the South African government’s attacks against transnational science in de-
fense of its territory and people (see Comaroff and Comaroff 2000). Even 
when these new formations reject or attack outright the biopolitical insti-
tutions of the nation- state (proposing an activist nongovernmental alterna-
tive), the nation- state remains the point of reference. This is why the term 
para- state, retaining the state in focus by directing one’s gaze slightly beside 
its original locus, seems suitable as a cover under which to explore the novel 
biopolitical spaces on the African continent.
Para- Statal Organizations
Specifically, we take the term from the para- statal scientific institutes, which 
were founded across Africa in the late 1970s as a new institutional form of 
the life sciences after the decline of national universities and government 
research bodies and in response to new transnational funding opportuni-
ties and changed scientific interests, practices, and technologies. These para- 
statal bodies are nominally “national”: linked to ministries and with politi-
cally appointed chairs, their names and rhetoric evoke the nation, and their 
legitimacy— scientific validity, ethic justification, and legal and economic 
accountability— is predicated upon this nation- state connection.2 Yet, at 
the same time, they are not integrated into governmental processes and 
resource flows or the national educational project—they don’t implement 
policy, spend tax revenue, or provide degrees.3 Instead, they are commonly 
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constituted as corporations, holding private property rights and assets and 
generate income and profits independent of the government budget. Apart 
from basic infrastructure, they are not government funded, and although 
nominally national, they depend upon transnational agencies and private 
partners’ support. They are collaborators: entities that can only exist in 
conjunction with something else, enacted and stabilized through practices 
glossed as collaboration—the contemporary version of the social contract— 
as implied by the prefix para- , “analogous or parallel to, but separate from or 
going beyond, what is denoted by the root word” (oed, online).
As the chapters in this collection illustrate, much bioscientific work in 
Africa today is conducted in para- statal frames, relating to but not part of 
the state, labeled variously as public- private partnership, collaboration, statu-
tory institution, nongovernmental organization, local partner: hiV positive 
populations (and care providers) depend upon treatment programs run by 
nations outside Africa, creating para- statal sovereignty and citizenship (see 
Nguyen and Poleykett in this volume); scientists in public African univer-
sities link, through citizens’ viral materials, to private U.S. university re-
searchers, founding new interstitial institutions and appropriating spaces 
left by receding national science (see Lachenal and Poleykett in this volume); 
para- statal research institutes in conjunction with a Euro- American national 
public health institution create scientific research stations and field sites (see 
Gerrets, Geissler, and Kelly in this volume); civil servants gain their living, 
expertise, and identity oscillating between state employment and trans-
national collaborations (see Whyte and Poleykett in this volume); patients 
move between attachments to transnational health care experiments and na-
tional referral institutions, making new associations in between (see Meinert 
and Poleykett in this volume); an African public institution conjoined with 
foreign private charities or corporations runs disease eradication programs 
(see Beisel in this volume); and all of a sudden, the allegedly dead nation- 
state raises its mighty head in nationalist (or Pan- Africanist) resilience to 
transnational scientific and economic intrusions (see Fassin, Kelly, and 
Geissler in this volume).
What can be designated as para- state is more or less prominent in differ-
ent countries and with regard to different institutions—and more or less 
camouflaged by nationalist discourse, which has a different historical root-
ing and salience in different African nations; in some cases, institutional 
segments of the nation- state are used or revived; in others, state forms are 
copied, referenced, or translated; and in other cases again, state functions are 
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picked up temporarily by non- state others. Moreover, the “slippery” (Ger-
rets in this volume) para- forms may look differently—and indeed operate 
to different effect—depending on one’s vantage point: for some they appear 
as genuinely national institutions, for others as fraudulent mirages of state-
hood, for others again as spaces in which (some) Africans play the games 
of foreign donors or as territories of opportunity that can be utilized, albeit 
indirectly, by national scientists for collective social interests. The diverse 
phenomena grouped by the term para- state have in common that the state 
remains an absent presence; like the blind spot at the center of the eye, the 
state is always part of the picture.
Collaborative Sites
An exemplary materialization of para- state science are the large, well- 
equipped, and highly productive research sites, which are featured in many 
of the chapters in this book, that have grown in most countries of sub- 
Saharan Africa since the 1980s, constituted of nominally national African 
institutions and governmental, public, or charitable bodies and leading uni-
versities in Europe or the United States (see, e.g., Crane 2011). They mark 
the northern partners’ spheres of interest in terms of study populations, 
clinical sites, and geographical- administrative areas, and they invest in infra-
structure such as buildings, laboratories, transportation, and staff within the 
demarcated and securitized spaces they control.4 While some of them have 
antecedents in the late colonial period (see, e.g., Kelly and Poleykett in this 
volume), most of them emerged during the past three decades.
As several chapters in this collection point out, rather than integrating 
research work into the existing geography of national health care provision, 
referral systems, public health programs, or national academic institutions, 
these sites often create separate spaces that provide perfect technical and 
managerial conditions for scientific work (International Organization for 
Standardization [iSo] accredited laboratories, high standards of health care 
and surveillance, controlled accounts, adherence to ethical regulations), set 
apart from the decaying governmental infrastructures around them. Due to 
their monopolization of technology, expertise, and participant access, they 
increasingly concentrate world- leading epidemiological laboratories and re-
search. This constitutes a shift, not only with respect to the developmental 
nation- state of immediate postcoloniality but also from the situation thirty 
years ago, when medical research was conducted by a multitude of overseas 
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and (African) national students and researchers using national infrastructure 
and attached to national ministries of health or universities.
Despite their impressive structures, these research sites are not perma-
nent, depending for resources and expertise on time- limited externally 
funded projects. The looming threat—characteristic for transnational out-
sourcing, for example, of manufacturing industries—that the foreign part-
ners move on to a different site and country means that national govern-
ments exercise only limited de facto control over these new entities.
The elusiveness of such science sites is part of their very constitution, 
which leaves many questions unanswered. Collaborative partnership empha-
sizes equality, symmetry, and mutual independence and glosses over diver-
gent interests, inequalities, and dependencies, as well as ambiguities and 
contradictions (Okwaro and Geissler 2015; for participants’ perspectives 
see also Molyneux et al. 2005). Who leads the collaboration? Who employs 
staff? Whom do staff, participants, and wider publics perceive as in con-
trol? Who is responsible for research outcomes and long- term effects and 
side effects? And who takes care of participants after a trial or in the case of 
adverse events? From these unanswered questions arises a configuration of 
power, which seems harder to contest (by actors or anthropologists) than 
older regimes of experimentation—for example, imperial scientific domi-
nation or contemporary for- profit clinical trials—where contradictions and 
conflicts of interest were more obvious.5
Given the independence of these entities from the nation- state, why is 
the state still necessary for para- statal science? The answer is that it provides 
legitimacy and rationale to the scientific undertaking: the national govern-
ment retains legal responsibility and liability for research activities; it under-
writes regulatory rules and provides ethics approval; it sets laboratory, phar-
maceutical, and professional standards (although increasingly transnational 
standards such as iSo and Good Clinical Practice [gcP] are adhered to).6 It 
allows legitimate access to citizens’ bodies and avails public medical facili-
ties for the recruitment of participants, for clinical trial procedures, and for 
the referral of participants after the end of research projects. And finally, it 
serves as the ultimate destination of findings, which ideally translate—after 
circulation through global scientific journals and health policy agencies—
into national health policies.7 Thus the state remains crucial to the activities, 
but it no longer functions as one center around and from which activities 
are assembled.8
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The Archipelago of Science
Para- state science sites are unlike national centers— public universities, re-
ferral hospitals, or government ministries—of nation- state science. These 
radiated across territory and population, extending the purview of scientific 
knowledge, making the population known, and applying and distributing 
knowledge to it. Instead, the para- statal configuration consists of networks 
of enclaves—specialized laboratories, clinical research centers, donor- run 
patient support centers, research wards, experimental huts and villages, and 
demographic surveillance systems. These are dotted across the nation, linked 
to one another and transnational circulations of expertise, data, resources, 
and policy, which crisscross the globe without necessarily touching upon 
national structures of knowledge generation and use. Thus, epidemiologi-
cal and demographic data produced in collaborative surveillance systems 
is analyzed by transnational scientists and institutions, before it is shared 
with local administration or national authorities; research wards cannot 
change care standards in surrounding hospitals or dispense care after the 
end of a trial; laboratories and data- processing units are established in air- 
conditioned high- quality buildings or pre- equipped containers adjacent to 
crumbling health facilities; transnational scientists working in these sites 
train their (African and overseas) graduate students in leading European 
and American universities, rather than national universities. While Thomas 
Moore’s archetypically modern republic of Utopia was an island governed 
from its center reaching out to its shores, the para- state configuration is in 
this instantiation an archipelago of well- protected islands of modern sci-
ence and government, enclosures in which the fruits of modernity—wealth, 
health, opportunity, innovation, freedom—are confined and contracted 
(Geissler 2013).
From a certain angle, this may not look so different from the past: iso-
lated mission hospitals in the jungle (see Manton in this volume), and colo-
nial nutrition experiments in the desert (see Kelly in this volume). As histo-
rians of colonial medicine have shown (e.g., Vaughan 1991), African public 
health and care provisions have always been patchy, and academic institu-
tions have always remained somewhat separate from their surroundings 
(see, e.g., Nyamnjoh 2004); there has never been a totalizing African re-
public of knowledge and welfare. The radical difference between the present 
archipelago and previous configurations is then not just the geographical 
forms—that science sites are not at the center of any territory, that bound-
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aries are fortified, and that circulatory flows are global—but the direction-
ality of relations between “islands” and remaining territory: early colonial 
hospitals were envisaged as bridgeheads for the arrival of modernity; de-
velopmental state experimental sites were envisaged as “pilots” for the sci-
entific government of national territory—both being mere starting points 
for larger projects. Contemporary enclosures of evidence production oper-
ate more like localized “sensors” of a global system; like weather stations, 
enclaved “surveillance systems” feed data into global knowledge streams, 
and while one hopes that this knowledge will have a benefit, somewhere and 
eventually, the connection between sensor and its surrounding is neither 
that between starting point and trajectory nor between model and reality.
The image of the archipelago emphasizes the isolation and separation 
of its constituent islands, and it is indeed one important trait of scientific 
spaces, like the above mentioned research stations, that they are fortified 
and accessible only to some. The way they are construed—administratively 
as well as architectonically—does pose an obstacle to localized circulation. 
At the same time, their boundaries are also always constituted by movement 
across them: by staff members entering in the morning and leaving in the 
evening; by research participants and biological specimens being brought 
there, and formal and informal information being taken outside; by clini-
cians moving between their commitments to transnational science, the gov-
ernment health care system, and their own private practices; by pharma-
ceuticals, money, and other forms of value circulating beyond their limited 
spaces. In other words, while these are enclosures, they are anything but 
hermetic, and their boundaries are demarcated in processes of continuous 
transgression. Rather than merely tracing new boundaries and discerning 
novel regimes, ethnography is to attend to these processes and pay attention 
to the less obvious relations between enclaves and the surrounding territory.
Science in Its Neoliberal Landscape
The archipelago of enclosures, superseding older versions of modernity 
as expanding, colonizing, encompassing, and improving territories and 
populations, is not limited to scientific production. Enclosures, enclaves, 
spaces of exception have been described by anthropologists such as Fergu-
son (2006) and Ong (2006) as characteristic expressions of a twenty- first- 
century political economy, reflected in phenomena as diverse as resource 
extraction arrangements, export production zones, and urban condomini-
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ums. The fact that publicly funded public health science and gold mines, 
sweatshops, and high- class urban enclaves share a similar geography today 
seems no coincidence; yet, as overarching causalities of the “neoliberaliza-
tion” type have limited explanatory value, the task for the anthropologist re-
mains to figure out relationships and interactions between similar patterns.
Widening economic differences, reflected in shrinking African govern-
ment budgets (further decreased by decades of misuse of funds), play a role. 
As national academic, scientific, and medical institutions lose their ability 
to perform their tasks, integration with well- resourced external institutions 
becomes more challenging, and the greater the discrepancy between re-
source rich entities and their surroundings, the greater is the need to con-
trol flows. Such economic effects are sharpened by the imprint of external 
partners’ policies and ideology: if the mandate of a foreign organization is, 
for example, to protect the health of its own population, then building a 
sustainable African national health system is not on the agenda; if the imagi-
nary of a big charity is focused on quick technological fixes achieved with 
high, targeted capital input, this does not favor health system integration.
Global technological, medical, and scientific developments contribute to 
these separations: bioscientific research has come to depend upon high- end 
technology with a rapid turnover and innovation rate—automated labora-
tory tools, sequencing equipment, Mri scanners, the newest diagnostic tests 
and reagents, high- speed data networks—and global rather than national 
standards, which carry high costs and complex international supply, main-
tenance, and training arrangements. If good science needs high capital input 
and innovation, driven and funded by global centers of excellence (such as 
Euro- American academia), then a structure of globally interconnected sci-
entific enclaves imposes itself.
Technological shifts are accompanied by changed management and the 
evaluation and audit of science: if valid outcomes—vital for sustained fund-
ing—are defined by publication in few world- leading journals and transla-
tion into global policy recommendations by transnational agencies, rather 
than in relation to local circulation, clinical practice, and public health inter-
vention, then the gap between transnational science production and na-
tional public health contexts necessarily widens (see, e.g., Feiermann 2011).
Finally, enclosures and scientific experiments share a topography and 
temporality. In order to achieve validity, experiments are confined to a par-
ticular place, different from the world at large (see, e.g., Gieryn 1983; Shapin 
1988): the scientific laboratory, or the experimental “field,” with its demar-
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cated territory and population. Spatial boundaries come with limitations in 
time: the experiment runs until it has achieved its predetermined outcome 
(open- ended experiments would imply different epistemology and political 
economy). The contemporary emphasis on valid experiments—epitomized 
in the proliferation of “randomized controlled trials” in public health re-
search and beyond it into social and economic policy—rather than, for ex-
ample, clinical, observational, or operational research, enforces the topog-
raphy of enclosure. The convergence between the topography of science and 
other political- economic processes can thus partly be explained with the par-
ticularities of the experiment itself. Experiments constitute states of excep-
tion, which anthropologists like Aiwa Ong (2006) or Mariella Pandolfi (e.g., 
Fassin and Pandolfi 2010), among others, identified as critical to the contem-
porary political- economic order, exemplified by phenomena as diverse as 
humanitarian emergencies and export production zones. Emergency inter-
ventions and economic zoning—experiments in their own right—are based 
on a state of exception, limited to a particular “hot spot” and the time of a 
“crisis.” As Nguyen and others show in their contributions to this collection, 
the global scientific response to the hiV crisis provides an exemplar for the 
convergence between experiment, emergency, and wider political economy 
and the processes of deterritorialization these entail.
New Collectives
In step with the deterritorialization of bioscientific work in para- statal sci-
ence, the collective that is the target of bioscience—the source and desti-
nation of its knowledge—has changed. The national citizenry, which was 
central to the nation- state’s efforts at generating and utilizing scientific 
knowledge, is turned into an assemblage of individual bearers of bodies 
and ailments, rights and claims, such as hiV “clients” in transnational treat-
ment programs or clinical trial “volunteers.” If these “somatic individuals” 
recollectivize in the process of their engagement with, for example, medi-
cal research, they do so not as one citizenry but as multiple and shifting 
new collectives: “peer groups,” “patient advocacy groups,” “community” 
representatives and advisory boards, and the like (see, e.g., Prince 2012a, 
2012b). These multiple, overlapping, and ephemeral biosocial collectives are 
governed by similar biopolitical techniques like the ones employed by the 
older, disciplining nation- state: registration and identity cards, statistics and 
demography, laboratory values and bodily measurements, enhanced with 
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contemporary biometrics, data networks, and satellite- based surveillance 
technology. And just like their common biopolitical ancestor, the national 
population, these collectives generate subjectivity, as exemplified by “hiV 
identities” (see Dilger 2009; Nguyen 2009) or by clinical trial participants’ 
sense of belonging (see Fairhead, Leach, and Small 2005; Geissler, Kelly, 
Pool, and Imoukhuede 2008).
What is different is their topography and timeline: the new biopoliti-
cal technologies do not usually create, or aim for, one larger, lasting col-
lective—as in the unitary civic public of the nation- state people, defined in 
terms of shared residence, biogenetic ties, language, or history— which can 
serve as a frame for political contestation and intentionality, as a target for 
education and science, and as a space to negotiate effects and distribution of 
scientific outcomes.9 Instead, they continuously evoke overlapping entities, 
which come and go, shrink and enlarge, overlap and merge—akin to media 
publics, constituted by ongoing processes of address, reception, and (mis)
translation. These multiple publics are still subject to governmentality, but 
they are not governed in one overarching direction—for example, popu-
lation well- being or improvement— but in many different (usually short- 
term) directions, shaped by contested interests.
Some anthropologists have attempted to capture these novel collectives 
in the idiom of multiple (biological) citizenships (e.g., Biehl 2004); while 
this can be fruitful (e.g., Petryna 2002), this becomes problematic if an infla-
tion of plural citizenships questions the privileged position of citizenship as 
social and political aim. Reserving the term citizenship for the latter encom-
passing project, by contrast, allows for the comparison of the implications 
and possibilities offered by diverse collectives and the assessment of their 
contribution to a larger emancipatory political project or not. Citizenship 
then remains a placeholder for an unfulfilled project, rather than a handy 
label. In a similar vein, the notion of the public— as in public health and 
public science— might best be reserved for particular formation of medical 
science and for a political direction in this regard.
Anthropologies of Public Science
The interest, across this edited volume, in the changing role of the state is 
linked to the fact that all contributions are about public health science: pub-
licly funded and publicly accountable biomedical work. Indubitably, the tex-
ture of “the public” has changed and its umbilical tie with the nation- state 
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has loosened (see, e.g., Prince and Marsland 2013). If the public evoked in 
Richard Titmuss’s writings on public health in postwar Britain referenced 
one lasting project, contemporary publics are multiple and have less defined 
territories: they may cover fragments of the older national public, combine 
pieces from different locations across levels of scale, or escape topographical 
and scalar location altogether. They wax and wane, merge and split up, are 
evoked and disbanded. And the distinction between public and private ap-
pears today often less obvious than in older versions of public health.
Yet, there remains an important conceptual and political difference be-
tween public science—as in spending tax revenue and being accountable 
to democratic institutions, led by publicly employed scientists publishing 
in academic journals, and referencing the social justice project of “public 
health”—and scientific research or health services for profit, conducted by 
pharmaceutical and biotech corporations. The promiscuous paradigm of 
“public- private partnership” and collaboration, discussed above, and the in-
trusion of corporate funding and models of intellectual property into aca-
demic institutions should not distract from this analytical and political dis-
tinction. Precisely because public science is today threatened, its particular 
frames and its actors’ intentions deserve attention— as reminders of past 
aspirations and to give orientation in ongoing struggles about the politics 
of science and health.
Recent anthropological literature on transnational medical research has 
focused on nonpublic medical charting of the “free market conversion of 
clinical research” (Elliott 2010) or even the emergence of “biocapitalism” 
(Rajan 2006), showing that global outsourced markets of human experi-
mentation have grown in recent years, being driven by the pharmaceutical 
industry’s search for surplus value, and that poorly regulated clinical trials 
have become part of the valorization of the human body in contemporary 
global bioeconomies (e.g., Cooper 2008; Fortun 2008; Fisher 2009; Petryna 
2009; Abadie 2010). Even if this literature might exaggerate the significance 
of bioeconomies, biological innovation- cum- exploitation is indeed a salient 
feature of contemporary public imaginaries of global futures—hence the 
resonance of the recent novels of, for example, Margaret Atwood (2003, 
2009) or Kazuo Ishiguro (2005).
However, it is no coincidence that most of these analyses focus not on 
Africa but on Eastern Europe and Southeast Asia, where (since the early 
1990s) poor medical care provision is combined with an underpaid but well- 
trained medical workforce and reasonably well organized public medical 
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institutions. Just as with other “free market conversions,” the new bioecon-
omy does not seem to work in quite the same way in most of Africa. Con-
trary to dark tales of the Constant Gardener type (Le Carre 2000) (echo-
ing the 1960s Tuskegee scandal [Reverby 2009]), in which Euro- American 
scientists, paid by inscrutable global corporations or, with equally sinister 
connotations, the U.S. government and army, experiment on black people 
to generate profits from vulnerable, disposable bodies, most medical re-
search in Africa today is open to public scrutiny, publicly funded (albeit 
not necessarily by the national government of the population enrolled of 
the trial), and by and large free from immediate corporate profit interests.10
To say that this research is more “public” is not simply to say that it is 
morally superior, but it poses different analytical and political challenges. 
For example, the aimed- for outcomes of public health research are more 
varied than those of industry research and development. Although (pub-
lic) drug and vaccine trials have become more common in Africa in recent 
years—partly in response to some large charities’ preference for pharmaceu-
tical rather than public health solutions (see, e.g., Biehl 2007)—much bio-
science experimentation in Africa is not after valuable new drugs but aims 
for affordable prevention strategies (see, e.g., Gerrets in this volume) or 
commercially marginal “adapted” medical solutions (see Kelly, Beisel, and 
Fassin in this volume).
The specificity of the African case lies, moreover, in the fact that most 
medical research in Africa today is conducted in collaborations between 
government institutions and public academic institutions in Africa and 
Europe and North America.
These institutions are usually mandated to pursue “public health” aims of 
equitable improvements to health, and although even public universities of 
course also pursue other, more managerial agendas, these stated intentions 
shape public representations of research institutions, personal justifications 
of scientists and other science workers, and the practices that produce public 
research, for example, justifying funding proposals, gaining ethics approval, 
motivating participants, negotiating research practices, and disseminating 
findings.
Such transnational collaborations are certainly shaped by unequal power 
and resources but not directly by profit calculations. In some trials, pharma-
ceutical multinationals contribute drugs or partial funding and thereby gain 
influence on the trial protocol and management, but even this involvement 
is often less for direct value creation motives qua experiment than for rea-
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sons of corporate image and tax savings.11 In these constellations, patterns 
of black and white, exploited and exploiter, are less clear- cut and thus more 
interesting for social anthropology: the world of public scientists and doc-
tors trying to generate knowledge between disparate locations and across 
wide differences of wealth and power—aiming for better knowledge and a 
common good—is closer to our own than that of multinational pharmaceu-
tical companies. Public health science constitutes, in principle, a critique of 
the conditions of inequality that cause much ill health and that commercial 
drug research and development, by contrast, uses for profit maximization. 
This difference is not trivial.
In order to critically scrutinize changing public health research, and to 
give political thrust to such scrutiny, the promise of public science, as in 
public good and public health, needs to remain a conceivable reality. Just 
as the nation- state cannot be discarded but is needed as a contrast to and 
ingredient in emergent forms of collectivization, sovereignty, and citizen-
ship, the public of public health, singular, serves as a heuristic device and 
political orientation. Seeing public science in Africa not as a mere version 
of contemporary “biocapitalism,” on a continuum with the use of humanity 
as source of primary accumulation, but as something different, pointing 
to different histories and social processes, guides analyses toward different 
political struggles. Public health science today is situated and implicated by 
the inherent, growing contradictions of the global political economy—on 
occasion threatened by being engulfed by it—but not coextensive with it.12
Parallels of Private and Public Science
Once we recognize these different structures and intentionalities, inter-
penetration and parallels between industry and public health science can 
be explored ethnographically. This may bring into view private scientists 
concerned with public interest or even resisting excessive profit maximiza-
tion (e.g., Petryna 2009; see also Sleeboom- Faulkner and Patra 2011), pri-
vate companies manipulating the idea of the public for profit (e.g., Hayden 
2007), pharmaceutical companies gaining influence in public hiV research 
(Nguyen in this volume), which in turn may open potential (publicly 
funded) drug markets, and public universities competing in markets of re-
search funding and policy influence (Crane 2011); and on a personal level, 
we see scientists make careers in public health research, attain degrees, make 
livelihoods, invest for old age, and educate their children.
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There are also striking topographical parallels between public and private 
science: industry clinical trials have become dispersed; no longer centered 
in Euro- American medical school hospitals, trials are spread between spe-
cialized subcontractors in diverse locations, from cheap U.S. motels to post-
industrial neighborhoods in South Asia; data (and profits) are concentrated 
in Switzerland or the United States, involving global transfers of resources, 
equipment, drugs, biological material, and data (Abadie 2010; Rajan 2006). 
A similar deterritorialization can be observed in public health research, 
though the motives are less unequivocal: for example, “multisite” clinical 
trials have become the new standard in hiV prevention and vaccine research, 
combining findings from multiple subpopulations spread across continents 
in order to accelerate findings and enhance their validity and applicability. 
Connected to this, much funding is invested into global networks of “demo-
graphic surveillance areas”—interlinked field research enclaves with highly 
controlled populations available for tightly regulated transnational trials. 
And while some biological materials still travel across the globe to special-
ized laboratories in leading universities, increasingly analyses are conducted 
on- site, in well- equipped collaborative research laboratories, from where 
data is pooled in northern public institutions, universities, or research con-
sortia.
Connected to these shifting geographies composed of globally networked 
enclosures, the temporality of public health science changed: originally con-
ceived within a long- term project of national melioration, and attending to 
entire human lifetimes, today timeframes are more limited. Experiments 
such as clinical trials have fixed endpoints, when data collection ends and 
research clinics cease to exist and patients—who have completed their role 
in the trial but not necessarily gained health—leave the trial clinic’s care. 
Moreover, recruitment for multisite trials is a race against time, in which 
sites compete to attract upcoming trials—sources of funding and future out-
put—or to contribute as many participants as possible to a global pool, be-
fore the globally determined sample size has been achieved—and thereby 
gain recognition and authorship. Such trials are not directly shaped by com-
petitive pharmaceutical markets and their search for profit, and their par-
ticipants or their specimens are not adequately described as commodities; 
yet there are obvious elements of market competition and managerial logic 
here, and the relationship with trial participants shows similar spatiotempo-
ral traits as competition- driven pharmaceutical research and development.
Another parallel development pertains to the role of scientists in pub-
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lic and private health research: just as global drug development is oper-
ated by an anonymous bureaucracy to which individual clinicians are mere 
“phantom investigators” with little control or scientific creativity (Fisher 
2009), scientists in large- scale public health trials are often far removed from 
actual clinical engagements, which are conducted as routine work by a local 
workforce, structured by detailed “standard operation procedures” (a con-
cept adapted from the military lexicon), and global standards set by the iSo 
or the International Conference on Harmonisation (ich) and overseen by 
site- Pis, so- called principal investigators who, contrary to their designation, 
are hired by the transnational trial management after the research proto-
col has been developed and approved and who thus bear little resemblance 
to the original principal investigator, as motor of intellectual innovation.13 
Again, while this process of “outsourcing” is not driven by profit maximi-
zation motives, similarities with dispersed and routinized practices of phar-
maceutical research and development are striking.
Finally, commercial and public research operate within the same context 
of economic, political, and scientific- technical inequality and face similar 
ethical and political problems—standards of care, regulatory weakness, ex-
posed populations. It does make a difference whether those conducting an 
experiment use poor participants, bad health care, and weak oversight to 
reduce costs and liability or whether they actively try to strengthen Afri-
can regulatory authorities, improve standards of care within the limits of 
public budgets, and employ globally agreed upon ethics codes (however 
weak these may be) to protect vulnerable participants. Yet irrespective of 
the actors’ different intentions, it remains a source of political contradiction 
that people suffering a high prevalence of disease and few medical provi-
sions rely upon clinical trials for their survival or that health professionals 
on low salaries in under- resourced facilities are dependent upon medical 
research to make ends meet and find professional satisfaction. This contra-
diction is obvious when it is cynically manipulated as a source of private 
gain; it becomes more interesting when this constellation is engaged by 
actors (and institutions) despite their stated intentions: when mobile pub-
lic scientists with egalitarian convictions engage these structures to pro-
duce public science—with the ultimate aim of reducing inequality and the 
suffering it creates; or when African scientists enact scientific partnerships, 
keenly aware of the fundamental inequalities that remain unaddressed by 
this idiom (Okwaro and Geissler 2015; see Redfield 2012; Wendland 2012). 
These contradictions, arising from trying to do the right thing in the wrong 
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context—trying to do something—produce public health science in Africa 
today. The ethical and political choices faced by public scientists under these 
conditions might not always differ from those involved in for- profit phar-
maceutical trials (see Petryna 2007; Patra and Sleeboom- Faulkner 2009); the 
difference is that whereas pharmaceutical research and development works 
in spite of personal dilemmas, public health research needs to address these 
contradictions; it cannot afford ignoring them if the public in public health 
is to make sense in the long term (Geissler 2013, 2014).
Ethnographies of Biopolitical Longing
Apart from the deliberate focus on public rather than private science, and 
connected to that on Africa, the chapters in this book—resulting from the 
authors’ ongoing conversation about medical science in Africa over several 
years— share some premises. First, none of the chapters portrays science as 
a complexity- reducing tool of (postcolonial) domination or (developmen-
tal) discipline; the anthropological “critique of biomedicine” is by and large 
absent. Partly this move away from the anxieties of 1980s medical anthro-
pology critique is because post- Foucauldian and post- Marxist analyses have 
become a foundation of our thinking, and partly because our interest has 
shifted back to the possibilities and responsibilities of science. It also may 
be shaped by the experience of fieldwork in an age of receding, crumbling 
medical services and growing medical needs, and among people who if any-
thing long for rather than loath the discipline and control that public health 
was once said to emanate (e.g., Lupton 1995). Indeed, most of the authors 
in this collection share a commitment to bioscience and public medicine— 
engaging an ethics of (always ambivalent and contested) “promise” rather 
than of suspicion and containment (see Fortun 2005). Even Nguyen’s “de-
constructing” analysis of hiV interventions in this volume aims ultimately 
for “meaningful long- term investment in public health.” Little can be heard 
here of the medical relativism of old, where people knew better than doc-
tors and biomedicine was just one, tainted and “reductionist,” knowledge 
among many; by contrast, the authors seem to accept the primacy and the 
desirability of medical science.
An associated shift applies—for many of the chapters—to perceptions of 
nation and state. The authors do not position “the state,” with its biomedi-
cal technologies, in opposition to people or locality, as in the “state versus 
people” imaginary of liberal anthropology (e.g., Scott 1998). Instead, they 
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share an interest in the mutual, open- ended constitution of health and larger 
collective forms and in the political possibilities of collectives engaged or 
evoked by scientific and medical action, including the collectives of state and 
nation. Beyond the celebration of ever- multiplying collectivities—publics, 
citizenships, sovereignties, “civil society”—they point toward the question 
of what it is that marks the singular national collective, and the nation- state, 
among this emergent multitude. This does not mean that all authors agree 
on a particular collective form—beyond political commitment to the pur-
suit of health as collective project—or unanimously long for the lost na-
tional collective of public health. But their analyses open up the way toward 
a new look of the nation as a particular frame for scientific work and public 
health.
The first two chapters, by Nguyen and Manton, set the stage with two 
contrasting arguments, one charting a radically transformed biopolitical 
landscape, the other one expressing doubts about its novelty. Reflecting 
on U.S.- funded hiV treatment programs, Nguyen discerns a new trans-
national regime in which African lives rely upon sovereignty beyond the 
control of “their” nation- state. Legitimate domination is here not only ex-
ercised through taking lives but also to maintaining them. The scope of 
aidS relief, dwarfing national medical budgets, combined with its sense of 
emergency, amounts to a “government by exception”: “experimentality” as 
global health’s new mode of governmentality. One could discuss whether 
the present constellation is “unprecedented” or extends colonial biopolitics 
and whether it comprises “entire populations,” since hiV sufferers remain a 
minority, and whether this description underrates the persistent purchase of 
the nation- state in citizens’ lives (as well as other sources of government—
for example, churches). Yet Nguyen’s hypothesis of a new mode of African 
medical- shaped governmentality provides an inspiring lead into the sub-
sequent chapters.
Manton, the only historian, expectedly objects to any “bland description” 
of the historical process in terms of grand transformations. He questions the 
contrast between the present constitution of science outside and beyond 
the state and an imaginary past of “successful integration of research and 
public health” around the monolithic figure of the nation- state. After a sen-
sitive ethnographic description of a Nigerian leprosarium in the present— 
ant- eaten patient files registering the dysfunction of health care and science, 
and the suffering of patients, doctors, and scientists—Manton examines the 
interactions between university laboratory, pharmaceutical industry, and 
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mission medicine in early postcolonial Nigerian leprosy research. He reveals 
a “collage of non- state actors” not dissimilar from the contemporary para- 
state and argues that the “reach of the state . . . always relied on the arms of 
missionaries, adventurers and capitalists.” This is a caveat against too clear- 
cut descriptions of the present by contrast to the past (and of the histori-
cal process as radical shift). At the same time, Manton’s cautious approach 
helps us to capture the prehistory of the present para- state in the “infancy of 
the elaboration of new global research relationships and capacities.”
The chapters by Lachenal and Geissler both engage critically with nar-
ratives of historical rupture—“neoliberalization” as extended biopolitical 
regime—one pointing to the futility and ineffectiveness of the supposedly 
disciplinary regime, the other tracing historically sedimented contradictions 
within its territory. Lachenal’s analysis of “extractive, privatized, and inter-
nationalized” Cameroonian virus research draws attention to a symptom-
atic, if not obvious, trait of contemporary science: “medical nihilism,” re-
flected in “non- interventionist interventions,” that is, outbreaks of intense 
but ineffective action, hyped- up “hotspots,” public health as performance 
and spectacle set against a backdrop of nonexistent or extremely deficient 
“real” public health. While such nihilism can be found in the colonial past 
(see Lachenal 2010), Lachenal suggests that it has become a central feature 
of the present. His description of highly publicized, well- funded, and self- 
consciously urgent “virological extraction” by entrepreneurial scientists 
from U.S. and European universities resembles the economic nihilism of 
speculative finance, underlining parallels between scientific and political- 
economic changes (despite the fact that the “virus hunting” is funded by 
Euro- American and Cameroonian state agencies, interspersed with specific 
commercial interests). Patterns of non- intervention, hubris, and absurdity 
in projects such as “viral forecast” and “epidemic preparedness” pose a chal-
lenge to late twentieth- century understanding, inspired by Foucault, of 
African public health as a “disciplinary” project. What emerges instead is 
a new pattern of biogovernment, maybe even (pace Nguyen’s hypothesis) 
an “anti- governmentality.” Lachenal emphasizes that his observations are 
derived from particularly futile “non- interventions” and suggests that on-
going hiV mass- treatment programs—instituted after this fieldwork—go 
beyond a mere “specter” of public health. Despite the obvious difference 
between life- sustaining treatment for millions and the imaginary of future 
viral threats, Lachenal’s attentiveness to “nihilism” is helpful to provide a 
constructive critique of hubris and absurdity, even within seemingly more 
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efficacious interventions, for example, the Presidential Emergency Program 
for aidS Relief (PePfar), a “historic commitment . . . the largest by any 
nation to combat a single disease” (PePfar website).
The logic of “non- intervention” could also be examined around the trans-
national clinical trial site described by Geissler, where three decades of major 
scientific discoveries that shaped global health policy effected few lasting 
improvements of the local health system. Instead, Geissler conducts an ar-
chaeological search, on the grounds of this “collaborative” site, for traces of 
alternative practices and imaginaries of public health research, contrasting 
to or conflicting with those dominating the present. Within the landscape of 
a research site dominated by hierarchies of collaboration and, seemingly, by 
one dominant model of transnational science associated with the era of neo-
liberalization, he traces different pasts (and past futures) that reveal nation-
alist visions of public health, contradictions and recalcitrance, and lasting 
claims for scientific melioration. Following some of the narrative fault lines 
embedded in this place of science, he opens up for diverse readings of the 
present and of future possibilities.
The next two pairs of chapters attend to the workings of bioscientific 
intervention. Gerrets and Whyte question the alleged disappearance of the 
state—one by attending to the nation’s persistent role as institution and 
vector of intentionality, the other by attending to the lasting appeal of gov-
ernment civil service. Whyte draws our attention to the many Ugandans 
who still are employed by government, derive vital sustenance from this, 
and dispense government services. This group continues to exercise soci-
etal influence, in spite of growing economic instability, and new, shifting, 
employment opportunities in the expanding nongovernmental sector and 
transnationally funded aidS interventions. Exploring “working- class citi-
zens’” (including health care workers’) experience, Whyte shows how the 
comparison between different ways of making a living—between the rela-
tive stability but poor remuneration of state employment and the lack of 
security in other kinds of work— forms a part of contemporary Ugandans’ 
lives and choices. The stability of government work not only pertains to gov-
ernment employees but also forms the backdrop to everybody else’s think-
ing about work, employment, and public health under conditions of gen-
eralized insecurity—be it in the informal business sector or in the world of 
temporary ngo contracts. Throughout Whyte’s account runs the notion of 
the “original Uganda,” which references, in the parlance of older Ugandans, 
the pre– civil war nation, marked by stable government employment and 
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collectively shared hopes in science- based futures. It is this “original” that 
across dysfunctional African nation- states lives on, both in the persistence of 
nation- state institutions and their employees and as memory and counter-
foil to present developments. As several of the chapters show, people, funds, 
and expertise move between state and non- state spaces, and government 
employment and newer forms of work—for example, public health inter-
ventions, medical research—often depend upon one another: pensionable 
employment in a university or ministry of health can serve as stable basis 
for temporary engagements with transnational interventions, and the legiti-
macy bestowed by public sector employment and standards can be trans-
ferred to nongovernmental opportunities and converted to higher yields.
These movements are obvious in Gerret’s ethnography of collaborative 
malaria research by Tanzanian and U.S. public institutions—a somewhat 
atypical “public- private partnership,” involving bilateral government inter-
actions and little private enterprise. His case presents a step up in scale in the 
experimentalization of public health, maybe indicative of emerging systems 
of global health governance: rather than citizens’ bodies, what is intervened 
upon here is the body of the nation (presumably unbeknown to patient- 
citizens)—its health policies, procurement, and clinical management. Ger-
rets confronts the “hybrid” quality of para- state science head- on—but ar-
rives at surprising outcomes: flexibility and openness, even “slipperiness,” 
function here as foundations of transnational collaboration, but these quali-
ties serve at the same time to promote a public, civic, and national agenda 
rather than particular interests external to the nation. In response to the 
moot trope of “inevitable globalization” (e.g., Kickbush 2003), Gerrets ar-
gues that transnational “global health” is necessary to counter the nation- 
state’s inability to deal with global (infectious) disease problems, and he 
reveals the lasting, crucial importance of nation- state government for al-
legedly “global” interventions, documenting the lasting appeal of the nation 
to public health actors (see also Wendland 2012). Gerrets shows those who 
argue that “global health” governance furthers the neoliberal demise of the 
nation- state and undermines sovereignty how state institutions and actors 
negotiate opportunities arising from “slippery” global partnerships to fur-
ther not only individual interests but also visions of social good, articulating 
civic commitments that can no longer be realized through emaciated nation- 
state structures alone: “the partnership’s malleability and its planners’ faith 
in flexibility and ambiguity opened up new opportunities for representatives 
of public sector institutions to assert their claims and pursue their interests, 
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fostering a para- statal space that enabled the state to reassert authority cor-
roded during the preceding era of neoliberal reforms.” The “slippery space” 
of para- state health science, then, is not opposed to the nation- state—as 
a panacea against its dysfunction or as a nail in its coffin: “The para- state 
space was at times quite distant from the state but on other occasions barely 
distinguishable from it.” In addition to this caveat against simple imaginar-
ies of contrast and shift, Gerrets draws our attention to “the variable forms 
that para- state spaces take across different historical and political economic 
context”: postsocialist Tanzania, different from, for example, neighboring 
Kenya or Uganda, maintains stable and visible government institutions, and 
Tanzanian doctors, scientists, and patients share decades of mass education 
and primary health care, which produced a particular vision of civic space, 
nation, and citizenship (see Langwick 2011).
The next two chapters, by Poleykett and Meinert, use ethnography of 
hiV research to attend to affective and relational dimensions, which further 
complicate narratives of rupture and transformation. Poleykett sets out to 
trace postcolonial “survivals” of sanitary regulation in contemporary trans-
national hiV research in Senegal. At first sight, her old state clinic, with a 
long- established cohort of prostitutes, providing archived data, insufficient 
care facilities, and regulatory means of enforcement to U.S.- based hiV re-
search teams, lends itself to a simple narrative of biopolitical domination, 
combining postcolonial governmentality and twenty- first- century biosci-
ence. However, looking closely at the “porous boundary between regulation 
and research,” observing everyday work at the clinic and in trials, Poleykett 
finds herself unable to discern any “single project” of “research piggyback-
ing” on postcolonial governmentality: “the two bureaucratic forms do not 
come together as part of a concerted effort and their interweaving is much 
more a product of care, obligation, reciprocity, curiosity, and creativity than 
cynical or opportunistic profiteering.” Somewhat counterintuitively, Poley-
kett observes that disciplinary medical practices, and even their architec-
tural framing by a distinctly colonial edifice, are appreciated as care, which 
is reminiscent of recent discussions about care in the social sciences (Mol 
2008) that fosters “deep mutual respect and care” between prostitutes and 
staff and a sense of belonging and citizenship: “the pleasures of member-
ship” within which even invasive clinical practices instill “feelings of security 
and pleasure.” For the mostly female state employees, mediating regulation, 
research, and care provides new opportunities and responsibilities, resem-
bling other anthropologist’s observations about changing gender roles and 
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social- professional mobility in transnational bioscience sites (see Meinert in 
this volume); in this case extra resources available from transnational col-
laboration do not simply represent additional income but also enable circu-
lation and opportunities to meaningfully deploy professional capacity. For 
the research participants, on the other hand, membership in the trial clinic 
allows new forms of association, like the formation of a radical sex worker 
organization, which gradually gains independence from the trial, enabling 
lay expertification and political struggle.
Meinert’s ethnography of one family’s engagements with a hiV research 
project conducted by the world’s largest public health agency in collabora-
tion with a Ugandan para- statal research institute shows that experimental 
networks intersect, extend, and play off against existing associations, ex-
pand and break existing relations and groups, and establish new ones. The 
research project creates new, bounded spatial formations on various levels 
of scale: through intensified technologies of surveillance, a “study area” is 
demarcated within which study participants must reside in order to bene-
fit from trial care and transport, a well- equipped “clinical research center” 
is carved out of the government hospital compound, and special rooms are 
set aside for research patients in the hospital ward. Yet while these consti-
tute enclosures, Meinert observes that their boundaries are crossed and that 
they also serve as embodiments of the desires, hopes, and expectations that 
patients and doctors initially bring to the bioscientific project—thus they 
constitute manifest structures of ex- and inclusion and discipline, but they 
also point beyond the present condition. Meinert also remarks upon the 
peculiar experimental temporality discussed above—research procedures, 
employment contracts, laboratory and clinical facilities, and not least anti-
retroviral treatment (art) are time- limited—and shows how patients and 
professionals think critically about these limitations, weighing short- term 
opportunities against long- term needs. The denizens of the experimental 
regime explore and use its opportunities rather than simply succumbing 
to experimental governmentality. Moreover, although the hiV experiment 
does constitute a rupture in governmental practices and people’s lives, there 
are continuities too: the family Meinert stays with, which is drawn into 
multiple engagements with the antiretroviral (arV) experiment (including 
the anthropologist’s choice of residence), is a chief ’s family with a mission 
background; experimentality is mapped here upon older forms of govern-
mentality; all protagonists continue to reckon with the nation- state, partly 
as memory, reference point for comparison with the past, partly as enduring 
introduction 31
contemporary structures, and partly, still, as a project, a hope for how things 
should become. Meinert’s careful documentation of the persistence of the 
state and the national collective in people’s lives contrasts sharply with the 
obliviousness to the state in the cited American researcher’s claims that there 
isn’t any national health system. Together with the preceding ethnographic 
chapters, Meinert’s case complicates the patterns drawn by historical rup-
tures, spatial enclosures, and temporal limitations.
The collection ends with three chapters engaging the changing nation 
itself: a multinational corporation taking the role of the nation, the perfor-
mance of nation- state territory in the operation of scientific models, and 
a case of two nation- states, South Africa and the United States, engaging 
in a contest on the territory of public health, science, and rationality. Bei-
sel’s example of a transnational gold- mining company that takes on national 
malaria control provides an extreme case of para- state science. Rather than 
a simple tale of corporate power usurping the nation- state, corporation and 
state fuse here, but the nation remains a source of legitimacy and authority, 
convincing citizens to submit to control practices by company employees 
and the Global Fund to avail US$158 million to a corporate responsibility 
program. There are some ruptures away from old- style nation- state public 
health: funding and expertise circulate in transnational networks, actions are 
governed by a company, interventions are time- limited projects, workers are 
company employees on temporary contracts. But there are also continuities, 
underlined by the aesthetic similarities between contemporary spray men 
and colonial public health spray teams. Public health interventions, notably 
in the developmental nation- state era, were marked by infinite, not rarely 
futile, iterations of action and experiment (for example, sleeping sickness 
control [Hoppe 2003; Malowany, Geissler, and Lwoba 2011]; public health 
administration [Lachenal 2010]; malaria and onchocerciasis eradication 
[Geissler 2011]; agriculture and nutrition [Bonneuil 2000]). The fusion be-
tween intervention and investigation in the contemporary campaign revives 
older features of national public health, maybe by contrast to the 1990s de-
tached transnational science as mere provider of evidence, to be “translated” 
via policy back into action.14 Similarly, the way in which Beisel’s control 
program engages its population—“top- down,” aiming for education and 
behavioral change—seems to refer back to older forms of government- led 
public health, prior to the era of “participation” and “community engage-
ment.” Beisel denounces the democratic deficit of such authoritative public 
health, especially in the hands of a mining company—legitimate claims to 
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company responsibilities are conveniently ignored. Yet it remains to be de-
bated whether Beisel’s recommendation to conduct malaria control as “real- 
world experiment” instead, drawing civic negotiation into scientific deci-
sion making, would remedy this democratic deficit. One might argue that 
the novelty of the current situation lies less in a particular form of “public 
engagement” in specific experimental activities (or the lack of it) and more 
in the lack of democratic organization and institutionalization of science on 
a national level of scale—due to the roles played by the multinational min-
ing corporation and the Global Fund. To remedy this democratic deficit, the 
inclusion of citizens into the nitty- gritty of a particular experiment may not 
be sufficient—potentially deflecting from the larger political task—to estab-
lish democratic governance.
Making explicit historical comparisons, Kelly explores how experimenta-
tion by British scientists in the miniature “laboratory nation” of the Gam-
bia articulates nationhood, expertise, and public health around the Second 
World War and in the present—the beginning and end of British- Gambian 
science. Relations between science and territory, and model and reality, have 
changed: the first experiment constructs a microcosm envisioned to be sub-
sequently expanded across territory, a “pilot” for national welfare and devel-
opment. The second experiment disconnects expert knowledge and national 
concern: transcending scalar modeling, it aims for translation into global 
policy; it is an exemplar of contemporary deterritorialized experimentation, 
by contrast to past governmental science (but see Beisel in this volume for 
corporate- cum- national public health as another possible realignment in the 
present). Underlying this change are continuities: both trials are part of the 
same British institutional setup; both are technical- cum- social experiments, 
which emplace scientific innovation, taking into account local social and eco-
nomic practices, incorporating populations and using local staff; and scien-
tific work relies in both cases upon particularities of place (and the labora-
tory scale of the mini- nation itself). Moreover, both experiments rely upon 
institutional assemblages: although funding changed from public sources to 
transnational big charity “collaboration” with the nation- state, unstable alli-
ances and unpredictable realignments are here found already before decolo-
nization, which thereby becomes prehistory rather than historical contrast 
(see also Manton in this volume). This pattern of continuity- in- change is 
personified by the village health workers used in the recent experiment: cre-
ated after the 1978 Alma Ata conference to build primary health with local 
volunteers as a national bottom- up project, they are revived in 2004 as trans-
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national research staff on temporary contracts; continuously linking govern-
ment, people, and the UK Medical Research Council (Mrc), they embody 
a new regime in an old form (see also Kelly 2011). Eventually, both experi-
ments fail to produce the anticipated extension in scale— one due to eco-
nomic pressures, the other due to environmental conditions—and while one 
results in a shift (back) from adapted technology to a plantation economy, 
the other ends with a decision to close down the research site altogether. At 
the end of her chapter, Kelly directs our imagination beyond the contempo-
rary biopolitical regime: the Mrc station is closed because, as Kelly argues, 
“long- term commitment to the Gambia is anachronistic . . . as research has 
less and less to do with specific places than with experimental networks”—
the archipelago turns into a mirage. Intertwined with this further deterrito-
rialization of science, the nation returns with a vengeance—maybe as a back-
lash—in the Gambian president’s militant (indeed violent) stance against 
multinational pharmacology and aidS treatment (see Cassidy and Leach 
2009). Like other antiscientific neo- nationalist public health outbursts else-
where in Africa (see Fassin in this volume), this may serve as a reminder of the 
risks entailed by visions of return to the national collective of public health.
Fassin’s “political biography of Nevirapine” charts the rise and fall of a 
wonder drug for the prevention of maternal transmission of hiV. The nar-
rative of media- amplified scientific and political hype—transnational scien-
tists and organizations build momentum around a health intervention and 
temporarily silence objections to full- scale “roll- out”—is familiar from the 
history of public health, from malaria eradication in 1955 to male circum-
cision in 2007. What is new in Fassin’s story is the role played by the state: 
this young nation- state calls for caution against the progress of science, even 
stops experimentation; it aligns itself with marginal scientists rather than 
dominant scientific institutions; it poses national public health concerns—
about drug resistance and the budget and the demographic effects of targeted 
hiV interventions—in opposition to a popular, rights- based demand for the 
extension of scientific discoveries. These public health arguments are inter-
twined with a nationalist discourse about protecting Africans from global 
exploitation, black bodies from white experiments; opposition to global sci-
ence becomes part of the nationalist struggle against racially defined trans-
national exploitation. This peculiar disjuncture between dominant science 
and national government is played out jointly with a third force, that of 
postliberation popular activism, which, while originally politically aligned 
with the new government, finds itself now scientifically opposed.
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While this narrative, the author claims, has no simple moral, it serves 
like the Gambian case as a caveat against the assumption that nation- state 
governments are either naturally aligned with science—sharing one modern 
rationality—or that the millennial nation- state has left the field of science 
to transnational experts and agencies. Here the state is a prominent science 
actor; by opposing the global rational consensus of scientists, the state re-
asserts its independence. This move appears on the surface as contrary to 
the widespread claims that the state’s role is weakening, notably in the field 
of health and science; this state is gaining strength, and it uses the biomedi-
cal controversy to make nationalist and in the broader sense “Africanist” 
assertions. Instead of positioning itself on the side of seemingly self- evident 
rationality, in this political constellation rationality and evidence are open 
to scientific and political contestation. Fassin’s observations underscore, 
again, the importance of history, implying both local specificity and global 
causality, to specific para- statal configurations. The fact that South Africa 
won independence recently and late, when the nation- state no longer pro-
vided the universally dominant model of political imagination, is the key to 
understanding the southern African biography of Nevirapine. Moreover, 
the constellation engaging nation- state government, transnational scien-
tists, and African clinicians and activists has its own historicity and evolved 
and changed dramatically over a short period of time.
The chapters below share attention to concrete practice, experience, and rela-
tions—within and beyond science—and respect for specific historical trajec-
tories and places. Originating from different disciplines, they are committed 
to new ways of integrating history and anthropology: interrogating histori-
cal remains ethnographically— be it Manton’s patient records or Geissler’s 
remains of older research stations; situating the ethnographic record within 
larger historical movements; and attending to historical comparisons drawn 
by the studied people. The chapters below constitute a critical conversation 
about the proposition that the postmillennial present constitutes a radi-
cal shift away from the mid- twentieth- century past. While several chapters 
attend empirically to both past and present, all contributors draw attention 
to certain convergent peculiarities of the present, “para- state” configura-
tion—notably territorial, temporal, and scalar changes—and describe recon-
figurations of familiar biopolitical entities—experimentality, transnational 
sovereignty, and alternative citizenships.
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While most observe discontinuities, the authors’ attention shifts quickly 
back to continuities, recurrences, traces, and memories. Framed by the 
two opening chapters, Nguyen’s euphoric incantation of radically “novel 
forms” of sovereignty and biopolitical domination and Manton’s historical- 
archaeological caveat against such claims to novelty, the contributors leave 
the classic anthropological- historiographic pendulum of continuity versus 
discontinuity to swing elsewhere and trace, instead, lines and lineages be-
tween past and present, applying the narrative of para- statal transformation 
as a heuristic device.
In this process, they qualify the initial proposition. Almost all empha-
size the continued relevance of the nation- state—as institutional framing, 
a source of legitimacy and authority, providing resources and study popu-
lations, as an association of people and source of livelihoods, as a rhetori-
cal device and project. Rather than postulating the replacement of the state 
by other forms of organized power, attention shifts to how it is that the 
state still works for science. Taking classic Foucauldian biopolitical govern-
mentality as a starting point, the authors are then less interested in dem-
onstrating how the older biopolitical apparatus morphs into an even more 
menacing disciplining machine—although Nguyen’s text alerts us to this 
somewhat threatening possibility. Instead, the idea of an extension of bio-
political discipline from past into present is problematized (together with 
the idea of totalizing governmentality), with reference to the contradic-
tions, persistent weaknesses and failures, resistances, and surprising out-
comes produced by “disciplinary” technologies. This opens an agenda for 
future research. What happens if science and government go different ways 
rather than colluding in a disciplinary project? How are seemingly absolute 
biometric forms of surveillance and control used and sabotaged? How do 
we deal with unpredictable processes of collectivization and consciousness, 
arising unintended from regulation and surveillance? Where does civic com-
mitment reside, if it can emerge from industry health interventions or post- 
neoliberal public- private partnerships? And, if the present is unpredictable, 
what is to happen next? Is the para- state of science the last step before sci-
ence is definitely disentangled from territory and population, as Kelly sug-
gests? Are we moving toward “global health” nihilism, performance and 
specter, or toward a global, transnational military- therapeutic complex—or 
both? What then about the manifold reformulations of the strong nation, 
be it through mining company public health or through counterfactual re-
jection of global scientific consensus? Is there hope for alternative outcomes, 
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scope for contradiction and struggle? True to the implications of the para- 
prefix, the para- state opens a space not only of menace and uncertainty but 
also of wonder and surprise.
Notes
This collection is the outcome of collaborative events supported by a Lever-
hulme Research Leadership Award (F/02 116/D). The index was prepared with 
the generous support of the Department of Social Anthropology, University of 
Oslo. Chapters 4 and 10 draw on materials generated as part of research funded 
by the Wellcome Trust (gr077430 and gr081507 respectively).
 1 For Nguyen, contemporary experimentality represents “an inversion of the clas-
sical model whereby evidence of efficacy permits intervention”; in the contem-
porary case, “intervention drives the need for self- validating evidence” (2009). 
This proposition may overemphasize change—did not colonial agricultural and 
economic interventions also function as experiments, continuously generating 
new data (see Bonneuil 2000)?—and overrates the significance of hiV; yet a 
strikingly new feature of contemporary African experimentality is that it often is 
inserted directly into national government; Nguyen’s example of PePfar pro-
grams is a case in point (for other hiV- related examples see the chapters by Fas-
sin and Meinert), but also the malaria trial discussed by Gerrets, in this volume, 
manipulates—viral style—entire government structures into an experimental 
configuration.
 2 As the historian of science Hutchinson shows in a forthcoming PhD thesis, the 
foundation of the new para- statals in the late 1970s was also in important ways 
a nationalist moment, irrespective of the early neoliberal context, and the overall 
outcomes of the scientific transformation that it engendered during subsequent 
decades (Hutchinson, forthcoming; see also Tousignant 2013; Droney 2014).
 3 It is precisely because contemporary collaborative science is not integrated in 
structures of academic education that “capacity building” has become a central 
concern of these institutions and their funders (see, e.g., Marjanovic et al. 2012). 
Although it certainly is laudable that the training of African scientists has be-
come an integral part of some funders’ policies, capacity building— usually not 
providing lasting support for national academic institutions and involving small 
numbers, often gaining degrees from European and American universities— 
remains an unanswered challenge.
 4 Financial investments in these sites are considerable. Although total funding 
amounts are difficult to assess because funding may be transferred along differ-
ent channels—core infrastructure funding, specific project funding from diverse 
funders, expatriate salaries, training programs for individual scientists, and so 
on—but for the larger sites, annual transfers can amount to tens of millions 
of dollars. The annual core grant for one such station in Kenya, for example, 
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amounted to about $30 million in 2008, excluding expatriate salaries and sepa-
rate project grants, dwarfing government budgets for medical research.
 5 The hard- to- grasp quality of the para- statal situation is evidenced by the al-
legedly “local” organizations that have emerged over the last few years around 
the major research centers, combining hiV care provisions (alongside but sepa-
rate from government health facilities) with scientific research. Nominally 
“local,” underlined by African language names, these are managed and staffed 
by leading North American universities (acting as their subsidiaries) and subsi-
dised by hiV aid moneys, notably from PePfar, which formally cannot be used 
for research but for “evaluation” of ongoing interventions.
 6 Good clinical practice (gcP) is a regulatory protocol, issued by the Interna-
tional Conference on Harmonisation (ich), which details practical procedures, 
including those pertaining to ethical matters (consent, incentives, etc.) around 
clinical trials. It has been endorsed by the World Health Organization (Who) 
and by the U.S. Federal Drug Administration (fda), which is responsible for 
licensing pharmaceuticals to the world’s largest pharmaceutical market, and it 
is therefore of crucial importance to the conduct of clinical trials all over the 
world, shaping widespread ideas about what the ethics of medical research are 
about (see, e.g., eMea 2002).
 7 While the rationale for transnational public health research remains, obviously, 
to inform policy, this process is complicated—probably more so than when re-
search was conducted by government institutions themselves. In the contem-
porary configuration, data usually have to travel several times around the globe, 
for processing and analysis, for peer- reviewed publication, and finally to get 
approval from organizations like the fda or Who, before they are turned into 
national policy, and even then material conditions and resource limitations can 
make implementation of findings difficult. In response to this hiatus, “research- 
to- policy” has emerged as an academic specialization, complete with its own 
dedicated journals, aiming to facilitate the process and thereby to maintain the 
legitimacy and purpose of transnational public health research (see, e.g., Gilson 
2008).
 8 Research in emergency situations (civil war, refugee camps, disease outbreaks) 
is an exception from this state reliance, as in these cases humanitarianism or 
international or corporate sovereignty may take the place of nation- state.
 9 This might be particularly the case in Africa. For a contradicting Southeast 
Asian case of contemporary biomedical nationalism, see, e.g., Reubi (2010).
 10 This does not mean that exploitative pharmaceutical experiments, which utilize 
weak regulatory and medical structures, high disease burdens, and treatment- 
naïve populations to conduct experiments with little oversight, do not occur 
in Africa. The 1996 Pfizer Trovan trial during a meningitis outbreak in Nigeria 
is the often cited example. See Sarah Boseley, “WikiLeaks Cable: Pfizer ‘Dirty 
Tricks to Avoid Clinical Trial Payouts,’” Guardian, October 12, 2010, http://
www.guardian.co.uk/business/2010/dec/09/wikileaks- cables- pfizer- nigeria; 
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see also the forthcoming anthropological work of Morenike Folayan and Kris 
Peterson on the subject.
 11 While northern agencies invariably portray their work as economically disinter-
ested, motivated by social good, some African para- statal research bodies have 
embraced a more entrepreneurial ethos of product development and profit gen-
eration in a bid to justify their existence in the changed climate of neoliberal re-
structuring (e.g., Langwick 2011).
 12 Cory Hayden’s (2003, 2007) work on bioprospecting benefit sharing and on 
pharmaceutical production in Mexico analyses anthropologically the reposi-
tionings and transformations of public- private divides, guided by an under-
standing of the public as political project.
 13 The emergence of the African “site- Pi” results from a paradoxical interaction 
between multisite trials designed and managed by a central northern agency 
and increasing political pressure toward greater “local” African participation. 
Thus, major American agencies insist today that Pis are recruited among Afri-
can scientists in collaborating institutions, while at the same time centralizing 
the process of research design and analysis in locations and among scientific staff 
outside of Africa.
 14 Hence, rather than epitomizing a radically new form, Beisel’s case inserts itself 
in an ongoing chain of transformation, beginning with malaria spraying as 
part of national and municipal public health, moving through transnational 
malaria science and policy from the 1960s Who “eradication” to the 1990s bed 
net trials sometimes directly involving chemical industry, to today’s contempo-
rary fusion of corporate- cum- national responsibility (which, in turn, reveals ties 
back to much older forms of corporate malaria control) (see Schumaker 2011).
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